speb/financial-data huggingface dataset:
4559.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 649989935.9673841
Net income (USD): 66622142.76166288
EPS growth %: 30.49948766225005
Revenue growth %: 16.702694180707756
EPS 2-year CAGR %: 19.571364484623377
Smoothed growth %: 19.571364484623377
P/E ratio: 9.756364911478276
P/B ratio: 1.0830146327610601
PEG ratio: 0.49850202928587595
Pays dividend: no
Net asset value (USD): 328687033.8190082
Net cash (USD): -305987789.06563294
Net cash to market cap %: -47.07577335181804
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.3473341572279725 (Grey Zone)
Piotroski F-score: 8 (Strong)
4559.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 573881580.7807808
Net income (USD): 52893793.79379379
EPS growth %: -20.60628553629912
Revenue growth %: -4.412522550083012
EPS 2-year CAGR %: 1.7882068862397071
Smoothed growth %: 1.7882068862397071
P/E ratio: 0.07157180634013906
P/B ratio: 0.8908840817242039
PEG ratio: 0.040024343318933474
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 430523973.973974
Net cash (USD): -271103178.1781782
Net cash to market cap %: -47.24026476147488
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.250446712178251 (Grey Zone)
Piotroski F-score: 6 (Neutral)
455A.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
455A.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: High)
Market cap (USD): 3816891.503100825
P/E ratio: 0.08217750670157567
P/B ratio: 2.2734048850472943
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 1682002.4295121795
Net cash (USD): 451262.7069880441
Net cash to market cap %: 11.822780569514233
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4564.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 225425393.11588264
Net income (USD): -21074750.04097689
P/B ratio: 13.890496905413105
Pays dividend: no
Net asset value (USD): 16228749.385346664
Net cash (USD): 9276667.759383708
Net cash to market cap %: 4.115183134942977
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 9.860248693830366 (Safe Zone)
Piotroski F-score: 1 (Weak)
4564.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 140662521.65165168
Net income (USD): -8398228.228228228
Revenue growth %: -9.883031129838043
Smoothed growth %: -9.883031129838043
P/B ratio: 21.909435203375242
Pays dividend: no
Net asset value (USD): 6420180.180180181
Net cash (USD): 3463701.2012012005
Net cash to market cap %: 2.462419385441559
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -6.865516607807292 (Distress Zone)
Piotroski F-score: 4 (Weak)
4564.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 55279417.6703645
Net income (USD): -8505929.741151612
Revenue growth %: -52.715509062830435
Smoothed growth %: -52.715509062830435
P/B ratio: 23.67054698757027
Pays dividend: no
Net asset value (USD): 2335367.1421024827
Net cash (USD): 92769.4136291598
Net cash to market cap %: 0.16781908626887332
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -35.268153192721655 (Distress Zone)
Piotroski F-score: 2 (Weak)
4564.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 74602459.67116696
Net income (USD): -5449037.561823285
Revenue growth %: 24.430306229712702
Smoothed growth %: 24.430306229712702
P/B ratio: 15.309060906966282
Pays dividend: no
Net asset value (USD): 4873091.832642695
Net cash (USD): 2725517.978879829
Net cash to market cap %: 3.6533888974886066
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -17.714540644835026 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4564.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 52374345.54554554
Net income (USD): -5697184.6846846845
Revenue growth %: 0.9046687278280474
Smoothed growth %: 0.9046687278280474
P/B ratio: 3.908304981229992
Pays dividend: no
Net asset value (USD): 13400782.032032032
Net cash (USD): 11711492.742742743
Net cash to market cap %: 22.361124746767956
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 6.897670560141262 (Safe Zone)
Piotroski F-score: 4 (Weak)
4570.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 24852171.158826426
Net income (USD): -2120693.3289624653
P/B ratio: 2.2161481763411066
Pays dividend: no
Net asset value (USD): 11214128.831339125
Net cash (USD): 1404359.9409932797
Net cash to market cap %: 5.650854132696214
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 3.1229006854866737 (Safe Zone)
Piotroski F-score: 1 (Weak)
4570.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 28336126.044144146
Net income (USD): -2175157.6576576577
Revenue growth %: 12.407707123717298
Smoothed growth %: 12.407707123717298
P/B ratio: 3.4992731324957167
Pays dividend: no
Net asset value (USD): 8097717.717717718
Net cash (USD): 1940262.7627627635
Net cash to market cap %: 6.847311307622207
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 3.901999528659317 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4570.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 32455654.54912837
Net income (USD): 1232791.8647649235
Revenue growth %: -9.6003658321889
Smoothed growth %: -9.6003658321889
P/E ratio: 26.326953865255447
P/B ratio: 3.8844871536879073
Pays dividend: no
Net asset value (USD): 8340068.674062335
Net cash (USD): 2514956.4183835187
Net cash to market cap %: 7.748900625549271
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 9.96265556856995 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4570.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 29751151.257184867
Net income (USD): 1664530.1430290067
EPS growth %: 35.0211816449981
Revenue growth %: 20.157382450237442
Smoothed growth %: 35.0211816449981
P/E ratio: 17.873603179721098
P/B ratio: 2.939439889154421
PEG ratio: 0.5103655085342871
Pays dividend: no
Net asset value (USD): 10109397.139419863
Net cash (USD): 3306376.1529207327
Net cash to market cap %: 11.113439356812274
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 10.012215955735927 (Safe Zone)
Piotroski F-score: 8 (Strong)
4570.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 56344555.75575575
Net income (USD): 2058402.152152152
EPS growth %: 23.662654039199435
Revenue growth %: -2.9708944850177756
EPS 2-year CAGR %: 29.21717251870708
Smoothed growth %: 29.21717251870708
P/E ratio: 0.23784407637098856
P/B ratio: 6.780317307285445
PEG ratio: 0.008140557619622587
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 11524543.293293294
Net cash (USD): 4240021.271271272
Net cash to market cap %: 7.525165855688093
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 19.44118421418712 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4574.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 356173593.8081775
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4574.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 147283008.06093892
Net income (USD): -36826662.65422811
P/B ratio: 2.4340242983289815
Pays dividend: no
Net asset value (USD): 58839903.70147458
Net cash (USD): -26316581.40234728
Net cash to market cap %: -17.868036339574687
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.2043146568928185 (Grey Zone)
Piotroski F-score: 2 (Weak)
4574.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 106450227.14558439
Net income (USD): -25532065.332673404
Revenue growth %: 14.12207957495376
Smoothed growth %: 14.12207957495376
P/B ratio: 2.234380472721876
Pays dividend: no
Net asset value (USD): 47634872.37502651
Net cash (USD): -7056494.3788446635
Net cash to market cap %: -6.628914346226804
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.3281438698283576 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4574.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 104175641.23240641
Net income (USD): 5720109.561118542
Revenue growth %: -7.379559165959945
Smoothed growth %: -7.379559165959945
P/E ratio: 18.21217585420432
P/B ratio: 2.053815636955354
Pays dividend: no
Net asset value (USD): 50550990.508949615
Net cash (USD): -2668959.806357093
Net cash to market cap %: -2.561980684527668
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.452820687543058 (Safe Zone)
Piotroski F-score: 8 (Strong)
4574.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 95986499.10903147
Net income (USD): 5901157.215011828
EPS growth %: 3.1651081497446416
Revenue growth %: 2.0457942357553547
Smoothed growth %: 3.1651081497446416
P/E ratio: 16.26570782843295
P/B ratio: 1.7625320880069986
PEG ratio: 5.139068574874845
Pays dividend: no
Net asset value (USD): 54242056.13451825
Net cash (USD): 3222300.364426825
Net cash to market cap %: 3.3570349938136617
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.018646945446281 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4577.T — Peter Lynch category analysis (quarterly, as of 2024-11-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 190041594.06191707
P/B ratio: 0.5522710504688673
Pays dividend: no
Net asset value (USD): 340881127.20777935
Net cash (USD): -161229079.8438844
Net cash to market cap %: -84.83883785533534
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4577.T — Peter Lynch category analysis (quarterly, as of 2025-05-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 190713199.8423981
P/B ratio: 0.5266434377502065
Pays dividend: no
Net asset value (USD): 357991375.7128947
Net cash (USD): -165043816.94255114
Net cash to market cap %: -86.54032184397322
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4577.T — Peter Lynch category analysis (quarterly, as of 2025-11-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 237349884.6707192
P/B ratio: 0.7105537991368313
Pays dividend: no
Net asset value (USD): 326906833.8878935
Net cash (USD): -143428461.7353468
Net cash to market cap %: -60.42912636520903
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4594.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 117241399.41812818
Net income (USD): -12163514.178003605
P/B ratio: 5.651172224956685
Pays dividend: no
Net asset value (USD): 20746385.83838715
Net cash (USD): 16925897.39386986
Net cash to market cap %: 14.436792359928733
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 29.64601933287555 (Safe Zone)
Piotroski F-score: 0 (Weak)
4594.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 179349021.53153157
Net income (USD): -11153400.900900902
Revenue growth %: -68.60832795412234
Smoothed growth %: -68.60832795412234
P/B ratio: 15.23999700677304
Pays dividend: no
Net asset value (USD): 11768310.810810812
Net cash (USD): 10488468.468468469
Net cash to market cap %: 5.848076771706545
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 104.08870860296068 (Safe Zone)
Piotroski F-score: 4 (Weak)
4594.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 59613901.44611728
Net income (USD): -7713166.930797676
Revenue growth %: -98.80060510012966
Smoothed growth %: -98.80060510012966
P/B ratio: 9.221714340143782
Pays dividend: no
Net asset value (USD): 6464513.998943476
Net cash (USD): 5322827.522451136
Net cash to market cap %: 8.928836048857221
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 16.404890148966924 (Safe Zone)
Piotroski F-score: 3 (Weak)
4594.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 40844897.98155327
Net income (USD): -7693817.6714343
Revenue growth %: 1492.752751414695
Smoothed growth %: 1492.752751414695
P/B ratio: 6.606817439399083
Pays dividend: no
Net asset value (USD): 6182234.995321481
Net cash (USD): 4109370.4050260657
Net cash to market cap %: 10.06091484640744
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 11.578619537883698 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4594.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 40840136.13613614
Net income (USD): -8164107.857857858
Revenue growth %: -93.0600945164052
Smoothed growth %: -93.0600945164052
P/B ratio: 4.046311308398904
Pays dividend: no
Net asset value (USD): 14817642.642642641
Net cash (USD): 12010673.173173174
Net cash to market cap %: 29.408993968915542
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 13.28288588476392 (Safe Zone)
Piotroski F-score: 4 (Weak)
4598.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 149219362.07179153
Net income (USD): -7927405.343386331
P/B ratio: 14.765100874906036
Pays dividend: no
Net asset value (USD): 10106220.29175545
Net cash (USD): 9648426.487461071
Net cash to market cap %: 6.465934684011769
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 112.94495224733194 (Safe Zone)
Piotroski F-score: 1 (Weak)
4598.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 109996592.04204205
Net income (USD): -9975885.885885887
Revenue growth %: -100
Smoothed growth %: -100
P/B ratio: 18.518178837661374
Pays dividend: no
Net asset value (USD): 5939924.924924925
Net cash (USD): 5470885.885885886
Net cash to market cap %: 4.973686715489191
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 61.76998780826126 (Safe Zone)
Piotroski F-score: 2 (Weak)
4598.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 78619646.55309033
Net income (USD): -9438675.382989964
P/B ratio: 9.658931572260919
Pays dividend: no
Net asset value (USD): 8139580.031695721
Net cash (USD): 7762579.239302695
Net cash to market cap %: 9.873587048067908
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 19.61186562126524 (Safe Zone)
Piotroski F-score: 3 (Weak)
4598.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 54666897.13941986
Net income (USD): -11503569.041571982
P/B ratio: 29.443302663455697
Pays dividend: no
Net asset value (USD): 1856683.598449405
Net cash (USD): 1218366.5285389652
Net cash to market cap %: 2.228709863359724
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -12.981870208613003 (Distress Zone)
Piotroski F-score: 1 (Weak)
4598.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 9255376.976976978
Net income (USD): -10172347.347347347
P/B ratio: 81.62903946322939
Pays dividend: no
Net asset value (USD): 212593.84384384385
Net cash (USD): -420645.64564564556
Net cash to market cap %: -4.544878579143929
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -82.91720109802257 (Distress Zone)
Piotroski F-score: 2 (Weak)
4631.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2004296529.442192
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
4631.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1451304321.8347878
Net income (USD): 140302437.55642492
P/E ratio: 10.344113381858545
P/B ratio: 0.4581165230504789
Pays dividend: no
Net asset value (USD): 2318936202.2269034
Net cash (USD): -5846892867.890461
Net cash to market cap %: -402.87159487671215
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.5811874993844341 (Distress Zone)
Piotroski F-score: 3 (Weak)
4631.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1675701795.2978148
Net income (USD): -274771972.0002828
EPS growth %: -295.8426216862974
Revenue growth %: -7.395828449772224
Smoothed growth %: -7.395828449772224
P/B ratio: 0.593573986602875
Pays dividend: no
Net asset value (USD): 2085986000.1414125
Net cash (USD): -5360171109.382733
Net cash to market cap %: -319.8761930329074
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.50665865107832 (Distress Zone)
Piotroski F-score: 4 (Weak)
4631.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1889256244.2007346
Net income (USD): 141665074.2085483
Revenue growth %: -7.102220098548993
EPS 2-year CAGR %: 0.48443352679157226
Smoothed growth %: 0.48443352679157226
P/E ratio: 13.336076338897183
P/B ratio: 0.7051444617454758
PEG ratio: 27.52921835782649
Pays dividend: no
Net asset value (USD): 2127052678.514555
Net cash (USD): -4738830498.757882
Net cash to market cap %: -250.83047962944187
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.6959952901365636 (Distress Zone)
Piotroski F-score: 9 (Strong)
4631.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2186312266.095379
Net income (USD): 212339364.49076146
EPS growth %: 49.88829510523671
Revenue growth %: -1.403311770005512
Smoothed growth %: 49.88829510523671
P/E ratio: 10.296311620497958
P/B ratio: 0.6966798036442904
PEG ratio: 0.2063873218914063
Pays dividend: no
Net asset value (USD): 2613260021.7377405
Net cash (USD): -4567086503.420498
Net cash to market cap %: -208.89451951788374
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.680571520084347 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4642.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 55009620.06376153
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4642.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 56097465.25864931
Pays dividend: no
Net asset value (USD): 40315942.43011348
Net cash (USD): 18696969.277608637
Net cash to market cap %: 33.329436885253685
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4642.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 59214183.584385626
P/B ratio: 1.2236582254636905
Pays dividend: no
Net asset value (USD): 34833635.956780255
Net cash (USD): -2535093.6640879773
Net cash to market cap %: -4.281227082148717
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4642.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 53019784.58458459
P/E ratio: 0.1004993628750595
Dividend yield: 0.02
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4678.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 21545543.43074906
Net income (USD): 342411.08015079494
P/E ratio: 62.92303222565281
P/B ratio: 0.5692557955285593
Pays dividend: no
Net asset value (USD): 36949426.32355352
Net cash (USD): -34592247.17259465
Net cash to market cap %: -160.55407135020687
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.451472680200622 (Distress Zone)
Piotroski F-score: 3 (Weak)
4678.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 20101841.590540543
Net income (USD): 1272034.5345345347
EPS growth %: 271.493391503085
Revenue growth %: -9.919515425508058
Smoothed growth %: 271.493391503085
P/E ratio: 15.80290553817098
P/B ratio: 0.5680422252158773
PEG ratio: 0.05820733039091824
Pays dividend: no
Net asset value (USD): 35126028.528528534
Net cash (USD): -26229609.60960961
Net cash to market cap %: -130.48361510296974
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5900276309325259 (Distress Zone)
Piotroski F-score: 8 (Strong)
4678.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Turnaround (confidence: High)
Market cap (USD): 12521725.067485474
Net income (USD): -2808432.382461701
EPS growth %: -320.7827151083888
Revenue growth %: -15.162847020060546
Smoothed growth %: -15.162847020060546
P/B ratio: 0.44078139429721697
Pays dividend: no
Net asset value (USD): 28263576.333861597
Net cash (USD): -22745562.59904913
Net cash to market cap %: -181.6487942073682
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5253674995165025 (Distress Zone)
Piotroski F-score: 4 (Weak)
4678.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 12188371.868667291
Net income (USD): 1992387.3813661274
Revenue growth %: 4.629610892515624
EPS 2-year CAGR %: 25.151897957510695
Smoothed growth %: 25.151897957510695
P/E ratio: 6.117470920895938
P/B ratio: 0.4019539780241919
PEG ratio: 0.243221045633623
Pays dividend: no
Net asset value (USD): 30201236.46571314
Net cash (USD): -23994185.269349016
Net cash to market cap %: -196.86128326155676
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5932629357940824 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4678.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 13516750.35035035
Net income (USD): 271083.5835835836
EPS growth %: -86.39403229919532
Revenue growth %: -6.200256908036547
Smoothed growth %: -86.39403229919532
P/E ratio: 0.32155602807776723
P/B ratio: 0.46671843541513575
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 29668049.2992993
Net cash (USD): -21401413.913913913
Net cash to market cap %: -158.33253821514276
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.6319627044715221 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4680.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Turnaround (confidence: Low)
Market cap (USD): 905534098.0338469
Net income (USD): 32265202.425831832
P/E ratio: 28.065346873784605
P/B ratio: 2.0236121505089555
Pays dividend: no
Net asset value (USD): 440796590.7228323
Net cash (USD): -465333551.8767415
Net cash to market cap %: -51.38774485545087
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.404100373089228 (Distress Zone)
Piotroski F-score: 3 (Weak)
4680.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 955261926.7186188
Net income (USD): 73100600.6006006
EPS growth %: 126.56172936970498
Revenue growth %: 34.95825676019827
Smoothed growth %: 126.56172936970498
P/E ratio: 13.067771247706688
P/B ratio: 2.2201439251626187
PEG ratio: 0.10325215460302263
Pays dividend: no
Net asset value (USD): 424587087.0870871
Net cash (USD): -1094429429.4294295
Net cash to market cap %: -114.56851768277411
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.2647144776663626 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4680.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 1320942125.1074352
Net income (USD): 65062070.78711041
EPS growth %: -10.996530462738967
Revenue growth %: -39.32559611383073
EPS 2-year CAGR %: 42.00274637578569
Smoothed growth %: 42.00274637578569
P/E ratio: 20.30279868327108
P/B ratio: 3.046795854612151
PEG ratio: 0.48336836124067145
Pays dividend: no
Net asset value (USD): 427852614.8969889
Net cash (USD): -910439778.1299525
Net cash to market cap %: -68.92351760346081
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.3850347785461594 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4680.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1697129308.9899747
Net income (USD): 28612484.961903486
EPS growth %: -56.02278775367234
Revenue growth %: -89.19363887632602
EPS 2-year CAGR %: -37.43703595177345
Smoothed growth %: -56.02278775367234
P/E ratio: 59.314292737930394
P/B ratio: 3.7966042763535777
Pays dividend: no
Net asset value (USD): 440823419.3289667
Net cash (USD): -948242213.6078064
Net cash to market cap %: -55.87330373618619
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.0936450568688791 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4680.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 1934048172.9729729
Net income (USD): 35372872.872872874
EPS growth %: 23.627405728550336
Revenue growth %: -0.005558990456708156
EPS 2-year CAGR %: -26.265417467871146
Smoothed growth %: 23.627405728550336
P/E ratio: 0.08052643286561414
P/B ratio: 2.5906481437545077
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 509547047.047047
Net cash (USD): -1067223473.4734734
Net cash to market cap %: -55.18081133589155
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.1637210451509332 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4705.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 18378775.29323062
Net income (USD): 1780749.0575315522
P/E ratio: 10.320811467229978
P/B ratio: 0.4300625100737553
Pays dividend: no
Net asset value (USD): 42568160.95722013
Net cash (USD): 25352704.474676285
Net cash to market cap %: 137.94555986553874
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.698348981344675 (Safe Zone)
Piotroski F-score: 3 (Weak)
4705.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 18205111.995795794
Net income (USD): 802342.3423423424
EPS growth %: -54.943548112582604
Revenue growth %: -16.177848444884212
Smoothed growth %: -54.943548112582604
P/E ratio: 22.689955440526983
P/B ratio: 0.47462018730982763
Pays dividend: no
Net asset value (USD): 37621058.55855856
Net cash (USD): 20473265.765765764
Net cash to market cap %: 112.45888391400045
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.829331816932345 (Safe Zone)
Piotroski F-score: 3 (Weak)
4705.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 19004729.055995777
Net income (USD): 579741.1516111991
EPS growth %: -27.743916652994493
Revenue growth %: -8.923529203844616
EPS 2-year CAGR %: -42.94211059899277
Smoothed growth %: -27.743916652994493
P/E ratio: 32.78140425805277
P/B ratio: 0.570135885704845
Pays dividend: no
Net asset value (USD): 31908815.37242472
Net cash (USD): 16183881.40517697
Net cash to market cap %: 85.15712777326408
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.941111346564252 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4705.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Speculative (confidence: Low)
Market cap (USD): 18646535.262665417
Net income (USD): -503101.189680524
EPS growth %: -186.78031364210048
Revenue growth %: 1.262078102341055
Smoothed growth %: -186.78031364210048
P/B ratio: 0.5813531549602237
Pays dividend: no
Net asset value (USD): 31181453.0143029
Net cash (USD): 15496464.376420265
Net cash to market cap %: 83.10640104517269
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.040506269478567 (Safe Zone)
Piotroski F-score: 3 (Weak)
4705.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Speculative (confidence: Low)
Market cap (USD): 17488099.2992993
Net income (USD): -541616.6166166166
Revenue growth %: -11.245115949109639
Smoothed growth %: -11.245115949109639
P/B ratio: 0.6125805565999559
Dividend yield: 0.05
Pays dividend: yes
Net asset value (USD): 29073955.205205206
Net cash (USD): 13358621.12112112
Net cash to market cap %: 76.38692400183457
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.834727649606151 (Safe Zone)
Piotroski F-score: 3 (Weak)
4714.T — Peter Lynch category analysis (annual, as of 2022-02-28)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category:  (confidence: Low)
Market cap (USD): 446190833.78093094
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4714.T — Peter Lynch category analysis (annual, as of 2023-02-28)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 366913041.32922536
Net income (USD): 10948884.976525823
P/E ratio: 33.511452729285146
P/B ratio: 5.348529414268196
Pays dividend: no
Net asset value (USD): 66804225.35211268
Net cash (USD): -11678058.978873238
Net cash to market cap %: -3.182786563422993
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 6.141399790396387 (Safe Zone)
Piotroski F-score: 4 (Weak)
4714.T — Peter Lynch category analysis (annual, as of 2024-02-29)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 226899271.0911987
Net income (USD): 11026038.762777114
EPS growth %: 0.7046725435211687
Revenue growth %: -7.430180691955327
Smoothed growth %: 0.7046725435211687
P/E ratio: 20.57849387009137
P/B ratio: 4.02894935817821
PEG ratio: 29.20291709857599
Pays dividend: no
Net asset value (USD): 54255933.89088013
Net cash (USD): -27551639.453073144
Net cash to market cap %: -12.142674289155906
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.864796525221395 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4714.T — Peter Lynch category analysis (annual, as of 2025-02-28)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 276585452.1738551
Net income (USD): 11619685.354309713
EPS growth %: 5.384042304809367
Revenue growth %: 4.111723231782636
EPS 2-year CAGR %: 3.017792014867071
Smoothed growth %: 3.017792014867071
P/E ratio: 23.803179151599853
P/B ratio: 3.4477593021381296
PEG ratio: 7.887614200824355
Pays dividend: no
Net asset value (USD): 77035024.33171122
Net cash (USD): -7486707.5528298095
Net cash to market cap %: -2.7068334556236318
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.012806426144133 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4714.T — Peter Lynch category analysis (annual, as of 2026-02-28)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 220716843.57756957
Net income (USD): 10367336.070832798
EPS growth %: -10.777824401350264
Revenue growth %: -1.3151816454679972
EPS 2-year CAGR %: -3.0330286756607316
Smoothed growth %: -10.777824401350264
P/E ratio: 21.289639119400093
P/B ratio: 2.8046245414175215
Pays dividend: no
Net asset value (USD): 74890080.84178108
Net cash (USD): -14885833.4402669
Net cash to market cap %: -6.744312395458557
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.452324427388359 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4760.T — Peter Lynch category analysis (annual, as of 2021-08-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category:  (confidence: Low)
Market cap (USD): 9641971.03511006
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4760.T — Peter Lynch category analysis (annual, as of 2022-08-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 7898288.987241405
Net income (USD): -964665.1769624451
P/B ratio: 0.9658771122315856
Pays dividend: no
Net asset value (USD): 8177322.857348808
Net cash (USD): -9129337.562171124
Net cash to market cap %: -115.58626908838494
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.143908058690882 (Grey Zone)
Piotroski F-score: 1 (Weak)
4760.T — Peter Lynch category analysis (annual, as of 2023-08-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Turnaround (confidence: High)
Market cap (USD): 6255937.508555784
Net income (USD): -2693928.8158795345
Revenue growth %: -9.159225686688943
Smoothed growth %: -9.159225686688943
P/B ratio: 0.9333949508431773
Pays dividend: no
Net asset value (USD): 6635886.379192335
Net cash (USD): -12701690.622861054
Net cash to market cap %: -203.0341672289707
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.419299728427397 (Distress Zone)
Piotroski F-score: 2 (Weak)
4760.T — Peter Lynch category analysis (annual, as of 2024-08-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 9231282.628200706
Net income (USD): 919835.7374560012
Revenue growth %: 14.792031484071405
Smoothed growth %: 14.792031484071405
P/E ratio: 10.035794710185707
P/B ratio: 0.9667644426968663
Pays dividend: no
Net asset value (USD): 9458810.131824143
Net cash (USD): -12751370.004831254
Net cash to market cap %: -138.13215907697386
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.9752329531924488 (Grey Zone)
Piotroski F-score: 9 (Strong)
4760.T — Peter Lynch category analysis (annual, as of 2025-08-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 11239798.896382589
Net income (USD): 869800.3951222836
EPS growth %: -5.439595386030647
Revenue growth %: 2.5841330434886762
Smoothed growth %: -5.439595386030647
P/E ratio: 12.922273845141683
P/B ratio: 1.0832461732600265
Pays dividend: no
Net asset value (USD): 10235567.817971252
Net cash (USD): -14314592.274678111
Net cash to market cap %: -127.35630242712894
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.080348965410563 (Grey Zone)
Piotroski F-score: 3 (Weak)
4820.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category:  (confidence: Low)
Market cap (USD): 345091831.5703114
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4820.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Health Information Services
Lynch category:  (confidence: Low)
Market cap (USD): 333460169.3952394
P/B ratio: 2.3516158532669698
Pays dividend: no
Net asset value (USD): 119672017.71381123
Net cash (USD): 15105175.754220873
Net cash to market cap %: 4.52982908921791
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4820.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category:  (confidence: Low)
Market cap (USD): 348691772.38253963
P/B ratio: 2.6696793831491026
Pays dividend: no
Net asset value (USD): 104654433.85972764
Net cash (USD): 4922958.890096538
Net cash to market cap %: 1.4118368370033414
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4820.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category:  (confidence: High)
Market cap (USD): 236020084.0840841
P/E ratio: 0.11483383156656089
Dividend yield: 0.04
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4833.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 116620184.72381577
Net income (USD): -3423619.0788395344
P/B ratio: 13.288107317146052
Pays dividend: no
Net asset value (USD): 6945861.334207507
Net cash (USD): 3943181.445664645
Net cash to market cap %: 3.3812169437075004
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 20.477515837295538 (Safe Zone)
Piotroski F-score: 0 (Weak)
4833.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Speculative (confidence: Low)
Market cap (USD): 64317100.37537538
Net income (USD): -3917394.894894895
Revenue growth %: -63.49967316191486
Smoothed growth %: -63.49967316191486
P/B ratio: 15.619143567136314
Pays dividend: no
Net asset value (USD): 4117837.837837838
Net cash (USD): 3096786.786786787
Net cash to market cap %: 4.814873134380964
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 65.50952471180919 (Safe Zone)
Piotroski F-score: 4 (Weak)
4833.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Speculative (confidence: Low)
Market cap (USD): 39311709.12572636
Net income (USD): -2057197.5699947174
Revenue growth %: -24.52863432198329
Smoothed growth %: -24.52863432198329
P/B ratio: 8.079458602270197
Pays dividend: no
Net asset value (USD): 4865636.555731643
Net cash (USD): 3643733.491811939
Net cash to market cap %: 9.268824919716879
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 34.107104086895134 (Safe Zone)
Piotroski F-score: 4 (Weak)
4833.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 38334174.47533752
Net income (USD): -2860159.0696430956
Revenue growth %: 17.819792480924104
Smoothed growth %: 17.819792480924104
P/B ratio: 18.571657217145777
Pays dividend: no
Net asset value (USD): 2064122.443523593
Net cash (USD): 414122.443523593
Net cash to market cap %: 1.0802957131371662
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 24.77114157489399 (Safe Zone)
Piotroski F-score: 2 (Weak)
4833.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Industrials | Industry: Consulting Services
Lynch category: Speculative (confidence: Low)
Market cap (USD): 19531323.323323324
Net income (USD): -13477533.783783784
Revenue growth %: 29.019590726980223
Smoothed growth %: 29.019590726980223
P/B ratio: 2.0157590525756137
Pays dividend: no
Net asset value (USD): 15097303.553553553
Net cash (USD): 1706168.6686686687
Net cash to market cap %: 8.7355507889793
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 10.341225451315353 (Safe Zone)
Piotroski F-score: 4 (Weak)
4845.T — Peter Lynch category analysis (annual, as of 2021-06-30)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 91863185.0651348
Net income (USD): 29182449.791930523
P/E ratio: 3.1478914799859132
P/B ratio: 0.9697812770366392
Pays dividend: no
Net asset value (USD): 72706441.10729147
Net cash (USD): -447575.5382666886
Net cash to market cap %: -0.48721970389916164
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.0839206115692988 (Grey Zone)
Piotroski F-score: 2 (Weak)
4845.T — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: High)
Market cap (USD): 74671702.5477707
Net income (USD): -3829248.114796105
EPS growth %: -113.12175003160621
Revenue growth %: -11.116267729883983
Smoothed growth %: -113.12175003160621
P/B ratio: 1.1324808423082096
Pays dividend: no
Net asset value (USD): 37425763.233033165
Net cash (USD): -15995087.488103077
Net cash to market cap %: -21.42054746625113
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.7141896498986533 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4845.T — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Technology | Industry: Software - Application
Lynch category: Speculative (confidence: Low)
Market cap (USD): 76797139.29755491
Net income (USD): -1471715.7065893079
Revenue growth %: 16.71267980612694
Smoothed growth %: 16.71267980612694
P/B ratio: 1.3744665993073948
Pays dividend: no
Net asset value (USD): 32303287.74692637
Net cash (USD): -17175431.689459875
Net cash to market cap %: -22.36467640143819
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.0578254406812873 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4845.T — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: High)
Market cap (USD): 67312035.75082457
Net income (USD): -17904748.273072377
Revenue growth %: -37.64235951367728
Smoothed growth %: -37.64235951367728
P/B ratio: 2.36707821940373
Pays dividend: no
Net asset value (USD): 20195594.000871245
Net cash (USD): -8171497.915240526
Net cash to market cap %: -12.139727797699871
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5861140913739793 (Distress Zone)
Piotroski F-score: 4 (Weak)
4880.T — Peter Lynch category analysis (quarterly, as of 2025-04-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 93209308.6416725
P/B ratio: 2.2300756013789673
Pays dividend: no
Net asset value (USD): 41400189.73998594
Net cash (USD): 23989880.534082923
Net cash to market cap %: 25.737644537530024
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4880.T — Peter Lynch category analysis (quarterly, as of 2025-10-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 65125636.74463937
P/B ratio: 1.6658016746044093
Pays dividend: no
Net asset value (USD): 38729246.26380767
Net cash (USD): 24071962.313190382
Net cash to market cap %: 36.96234465634119
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)